1.
Gärtner F, Aßmus J, Fløtten Øystein, Paula Ramnefjell M, Aanerud M. Characteristics and survival of patients with non-small cell lung cancer treated with immune-checkpoint inhibitors in the real-world: experiences from Bergen, Norway. AO [Internet]. 2022 Jul. 3 [cited 2024 Nov. 24];61(7):814-8. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/23524